You are here: Home Experience Services Centrovet


Date November, 2021
Client Centrovet
Counterparty Virbac
Industry Animal health
Amount US$47.4 million
Landmark Alantra acted as financial advisor on the sale of the remaining 34% of Centrovet to Virbac, the world’s sixth largest animal health global company, for a total consideration of USD 47.4 million (including earnout).
Established in 1979, Centrovet is Chile’s second largest producer of salmon vaccines and has developed a leading position in aquaculture and animal health generally. 
Virbac is a leading animal health company present in more than 100 countries around the world and covering more than 50 species. The company is listed on the Euronext Paris stock exchange (Euronext:VIRP) and has a market capitalization of EUR 3.5 billion.